AHR and neoplasm: Ablation of AhR (as seen in MOC1AhR KO cells) results in attenuated tumour growth within 1 week, leading to complete rejection within 2 weeks, along with an augmentation of activated T cells in tumour-draining lymph nodes (tdLNs) and enhanced T cell signalling within the tumour [92].